Effects of hyperglycemia, glucagon, and epinephrine on renal glucose release in the conscious dog

Metabolism: Clinical and Experimental

Volumn 53, Issue 7, 2004, Pages 933-941

  Gustavson, Stephanie M ^a,b   Chu, Chang An ^a   Nishizawa, Makoto ^a   Neal, Doss ^a   Farmer, Ben ^a   Yang, Ying ^a   Donahue, E Patrick ^a   Flakoll, Paul ^a   Cherrington, Alan D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOG; FEMALE; GLUCONEOGENESIS; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RENAL DIABETES;

AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; DOGS; EPINEPHRINE; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; INSULIN; KIDNEY; LACTIC ACID; MALE;

EID: 3042661013     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.01.018     Document Type: Article

References (45)

1. Biava C., Grossman A., West M. Ultrastructural observations on renal glycogen in normal and pathologic human kidneys. Lab Invest. 15:1966;330-356
2. Ekberg K., Landau B.R., Wajngot A., et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes. 48:1999;292-298
3. Cersosimo E., Judd R.L., Miles J.M. Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest. 93:1994;584-2589
4. Cersosimo E., Garlick P., Ferretti J. Insulin regulation of renal glucose metabolism in humans. Am J Physiol. 276:1999;E78-E84
5. Stumvoll M., Chintalapudi U., Perriello G., et al. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest. 96:1995;2528-2533
6. Stumvoll M., Meyer C., Mitrakou A., et al. Renal glucose production and utilization New aspects in humans. Diabetologia. 40:1997;749-757
7. Gerich J.E., Meyer C., Woerle H.J., et al. Renal gluconeogenesis Its importance in human glucose homeostasis. Diabetes Care. 24:2001;. 982-391
8. Ekberg K., Landau B.R., Wajngot A., et al. Splanchnic and renal glucose production in the postabsorptive state in healthy humans. Diabetologia. 41:1998;A202. (abstr)
9. McGuinness O.P., Fugiwara T., Murrell S., et al. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol. 265:1993;E314-E322
10. Cherrington A.D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes. 48:1999;1198-1214
11. McGuinness O.P., Burgin K., Moran C., et al. Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. Am J Physiol. 266:1994;E438-E447
12. McGuinness O.P., Shau V., Benson E.M., et al. Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog. Am J Physiol. 273:1997;E674-E681
13. Cersosimo E., Molina P.E., Abumrad N.N. Renal glucose production during insulin-induced hypoglycemia. Diabetes. 46:1997;643-646
14. Cersosimo E., Molina P.E., Abumrad N.N. Renal lactate metabolism and gluconeogenesis during insulin-induced hypoglycemia. Diabetes. 47:1998;1101-1106
15. Cersosimo E., Zaitseva I.N., Ajmal M. Effects of beta-adrenergic blockade on hepatic and renal glucose production during hypoglycemia in conscious dogs. Am J Physiol. 275:1998;E792-E797
16. Meyer C., Dostou J.M., Gerich J.E. Role of the human kidney in glucose counterregulation. Diabetes. 48:1999;943-948
17. Cersosimo E., Garlick P., Ferretti J. Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes. 48:1999;261-266
18. Cersosimo E., Garlick P., Ferretti J. Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes. 49:2000;1186-1193
19. Cersosimo E., Garlick P., Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes. 50:2001;2087-2093
20. Bowman R.H. Gluconeogenesis in the isolated perfused rat kidney. J Biol Chem. 245:1970;1604-1612
21. Stumvoll M., Meyer C., Kreider M., et al. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism. 47:1998;1227-1232
22. Kurokawa K., Massry S.G. Evidence for stimulation of renal gluconeogenesis by catecholamines. J Clin Invest. 52:1973;961-964
23. Conjard A., Martin M., Guitton J., et al. Gluconeogenesis from glutamine and lactate in the isolated human renal proximal tubule Longitudinal heterogeneity and lack of response to adrenaline. Biochem J. 360:2001;371-377
24. Ikeda T., Iwata K. Enhanced adrenergic mechanisms in glucose output from the kidney of diabetic rats. Metabolism. 52:2003;. 772-475
25. Meyer C., Stumvoll M., Welle S., et al. Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am J Physiol Endocrinol Metab. 285:2003;819-826
26. Meyer C., Stumvoll M., Welle S., et al. Sites, substrates, and mechanisms of epinephrine stimulated glucose production in humans. Diabetes. 47:1998;A305. (abstr)
27. Gustavson S.M., Chu C.A., Nishizawa M., et al. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. Am J Physiol Endocrinol Metab. 284:2003;E695-E707
28. Chu C.A., Sindelar D.K., Neal D.W., et al. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest. 99:1997;1044-1056
29. Sherck S.M., Shiota M., Saccomando J., et al. Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input. Diabetes. 50:2001;2487-2496
30. Moller N., Rizza R.A., Ford G.C., et al. Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers. Diabetes. 50:2001;747-751
31. Joseph S.E., Heaton N., Potter D., et al. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes. 49:2000;450-456
32. Cersosimo E., Ajmal M., Naukam R.J., et al. Role of the kidney in plasma glucose regulation during hyperglycemia. Am J Physiol. 272:1997;E756-E761
33. Stumvoll M., Meyer C., Perriello G., et al. Human kidney and liver gluconeogenesis Evidence for organ substrate selectivity. Am J Physiol. 274:1998;E817-E826
34. Meyer C., Stumvoll M., Dostou J., et al. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol Endocrinol Metab. 282:2002;E428-E434
35. Stumvoll M., Perriello G., Meyer C., et al. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int. 55:1999;778-792
36. Brundin T., Wahren J. Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man. Am J Physiol. 267:1994;E648-E655
37. Felig P., Owen O.E., Wahren J., et al. Amino acid metabolism during prolonged starvation. J Clin Invest. 48:1969;584-594
38. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am. 18:1989;103-121
39. Meyer C., Stumvoll M., Nadkarni V., et al. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest. 102:1998;619-624
40. Bjorkman O., Felig P., Wahren J. The contrasting responses of splanchnic and renal glucose output to gluconeogenic substrates and to hypoglucagonemia in 60-h-fasted humans. Diabetes. 29:1980;610-616
41. Owen O.E., Felig P., Morgan A.P., et al. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 48:1969;574-583
42. Meyer C., Dostou J.M., Welle S.L., et al. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab. 282:2002;E419-E427
43. Meyer C., Dostou J., Nadkarni V., et al. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism. Am J Physiol. 275:1998;F915-921
44. Cersosimo E., Garlick P., Ferretti J. Regulation of splanchnic and renal substrate supply by insulin in humans. Metabolism. 49:2000;676-683
45. Woerle H.J., Popa E., Dostou J., et al. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance. Metabolism. 51:2002;1494-1500